{"database": "lobbying", "table": "lobbying_activities", "rows": [[1261079, "b23da46a-4741-474e-a9be-6819748f42c9", "Q2", "TURNER & GOSS LLP", 316310, "CANCER LEADERSHIP COUNCIL", 2012, "second_quarter", "MED", "Drug shortage provisions as included in the Food and Drug Administration Safety and Innovation Act", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2012-07-12T12:40:36.023000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1261079"], "units": {}, "query_ms": 41.08048597117886, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}